Please wait a minute...
浙江大学学报（医学版）
浙江大学学报（医学版）  2013, Vol. 42 Issue (3): 326-330    DOI: 10.3785/j.issn.1008-9292.2013.03.012
论著     
右美托咪定预处理减轻离体大鼠心脏缺血/再灌注损伤的线粒体相关机制
姜翠翠，夏满莉，王敏，陈士票
嘉兴学院医学院，浙江 嘉兴 314001
Dexmedetomidine preconditioning protects isolated rat hearts against ischemia/reperfusion injuries and its mechanism
 JIANG Cui-Cui, XIA Man-Li, WANG Min, CHEN Shi-Piao
Jiaxing University College of Medicine,Jiaxing 314001,China
 全文: PDF(791 KB)   HTML ( ) 
摘要：

目的：研究右美托咪定（dexmedetomidine，Dex）预处理对心肌缺血/再灌注（I/R）损伤的作用及其与线粒体渗透性转换孔（mPTP）和/或线粒体ATP敏感性钾通道（mitoKATP）的关系。方法：分离SD雄性大鼠心脏置于Langendorff系统行全心停灌30 min，再灌注120 min建立心肌I/R损伤模型，停灌前15 min给予Dex（10 nmol/L）处理。测定左心室动力学、再灌注期间冠脉流量及再灌注5 min时中乳酸脱氢酶（LDH）含量，实验结束测定心肌组织formazan含量以反映心肌梗死状况。结果：与正常对照组相比，I/R组明显降低了再灌注期间的左室发展压、冠脉流量及再灌注末心肌组织formazan含量，显著升高了再灌注左室舒张末压、心肌LDH渗出；Dex预处理明显改善了I/R心脏功能及心肌组织活性（P<0.01）；mPTP开放剂苍术苷（20 μmol/L，再灌注前给药20 min）及mitoKATP抑制剂5-羟基癸酸（100 μmol/L，停灌前给药20 min）可取消Dex预处理产生的抗心脏I/R损伤作用。结论：围手术期常用的辅助麻醉药Dex具有减轻离体大鼠心脏I/R损伤作用，且该心肌保护作用可能与Dex促进缺血前mitoKATP的开放，抑制再灌注早期mPTP的开放有关。
关键词： 右美托咪啶/治疗应用;  缺血预处理;  心肌/药物疗法;  线粒体/药物作用;  钾通道/药物作用;  腺苷三磷酸酶类/代谢;  心肌再灌注损伤/预防和控制    
Abstract:

Objective： To investigate the protective effect of dexmedetomidine (Dex) preconditioning against ischemia/reperfusion (I/R) injuries in isolated rat hearts and its relation to mitochondrial permeability transition pore (mPTP) and mitochondrial ATP-sensitive K+ channel (mitoKATP). Methods： The hearts of male SD rats were isolated to mount on the Langendorff apparatus and subjected to 30 min global ischemia followed by 120 min reperfusion.The isolated hearts were treated with Dex (10 nmol/L) before ischemia for 15 min.The left ventricular hemodynamic parameters,coronary flow (CF) and the lactate dehydrogenase (LDH) release in the coronary effluent at 5 min reperfusion were measured.The formazan content was assayed to determine the myocardial viability at the end of reperfusion. Results： Compared with normal controls,I/R markedly decreased the left ventricular developed pressure and CF during the whole reperfusion period and the formazan content; while the left ventricular end diastolic pressure and LDH release were significantly increased.Dex preconditioning markedly improved the myocardial viability and cardiac function (P<0.01),which were reversed by the treatment with both atractyloside (20 μmol/L before ischemian),an opener of mPTP,and 5-hydroxydecanoate (100 μmol/L at the beginning of reperfusion),an inhibitor of mitoKATP,for 20 min. Conclusion： Dex has protective effect against I/R injuries in isolated rat hearts,which may be related to inhibiting the opening of mPTP at the beginning of reperfusion and activating mitoKATP before ischemia.
Key words: Dexmedetomidine/therapeutic use    Ischemic preconditioning    myocardial/drug therapy    Mitochondria/drug effects    Potassium channels/drug effects    Adenosine Triphosphatases/metabolism    Myocardial reperfusion injury/prevention &    control
收稿日期: 2012-02-29 出版日期: 2013-05-25
CLC:  R 331.3  
基金资助:

浙江省嘉兴市科技局科研项目资助（2010AY1061）.
作者简介: 姜翠翠（1991-），女，本科生.
服务　　
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章　　
姜翠翠
夏满莉
王敏
陈士票

引用本文:

姜翠翠, 夏满莉, 王敏, 陈士票. 右美托咪定预处理减轻离体大鼠心脏缺血/再灌注损伤的线粒体相关机制[J]. 浙江大学学报（医学版）, 2013, 42(3): 326-330.

JIANG Cui-Cui, XIA Man-Li, WANG Min, CHEN Shi-Piao. Dexmedetomidine preconditioning protects isolated rat hearts against ischemia/reperfusion injuries and its mechanism. Journal of ZheJiang University(Medical Science), 2013, 42(3): 326-330.

链接本文:

http://www.zjujournals.com/med/CN/10.3785/j.issn.1008-9292.2013.03.012    或    http://www.zjujournals.com/med/CN/Y2013/V42/I3/326

\
[1\]BRAUNWALD E,KLONER R A.Myocardial reperfusion:a double-edged sword? \
[J\]. J Clin Invest,1985,76(5):1713-1719.
\
[2\]KATARE R G,ANDO M,KAKINUMA Y,et al.Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of the bradycardiac effect \
[J\]. J Thorac Cardiovasc Surg,2009,137(1):223-231.
\
[3\]WIJEYSUNDERA D N,NAIK J S,BEATTIE W S.Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications:a meta-analysis \
[J\]. Am J Med,2003,114(9):742-752.
\
[4\]OKADA H,KURITA T,MOCHIZUKI T,et al.The cardioprotective effect of dexmedetomidine on global ischaemia in isolated rat hearts \
[J\]. Resuscitation,2007,74(3):538-545.
\
[5\]GUO H,TAKAHASHI S,CHO S,et al.The effects of dexmedetomidine on left ventricular function during hypoxia and reoxygenation in isolated rat hearts \
[J\]. Anesth Analg,2005,100(3):629-635.
\
[6\]HALESTRAP A P.Calcium,mitochondria and reperfusion injury:a pore way to die \
[J\]. Biochem Soc Trans,2006,4(Pt 2):232-237.
\
[7\]GAO Q,PAN H Y,QIU S,et al.Atractyloside and 5-hydroxydecanoate block the protective effect of puerarin in isolated rat heart \
[J\]. Life Sci,2006,79(3):217-224.
\
[8\]WONG E S,MAN R Y,VANHOUTTE P M,et al.Dexmedetomidine induces both relaxations and contractions,via different {alpha}2-adrenoceptor subtypes,in the isolated mesenteric artery and aorta of the rat \
[J\]. J Pharmacol Exp Ther,2010,335(3):659-664.
\
[9\]ARCANGELI A,D′AL  C,GASPARI R.Dexmedetomidine use in general anaesthesia \
[J\]. Curr Drug Targets,2009,10(8):687-695.
\
[10\]TERASHIMA Y,SATO T,YANO T,et al.Roles of phospho-GSK-3β in myocardial protection afforded by activation of the mitochondrial K ATP channel \
[J\]. J Mol Cell Cardiol,2010,49(5):762-770.
[1] . 七氟醚预处理对大鼠产生延迟相的心肌保护作用[J]. 浙江大学学报（医学版）, 2012, 41(5): 553-558.
[2] . 硫化氢预处理延迟相对大鼠心肌缺血再灌注时谷胱甘肽S转移酶表达的影响[J]. 浙江大学学报（医学版）, 2011, 40(5): 535-539.
[3] . 线粒体钙单向转运体在缺血后处理中对心肌保护的作用[J]. 浙江大学学报（医学版）, 2011, 40(3): 304-308.
[4] 夏强，钱令波. 心脑缺血再灌注损伤的机制及防治策略研究进展[J]. 浙江大学学报（医学版）, 2010, 39(6): 551-558.
[5] 何萍;范彦英;章露易;胡薇薇;陈忠. 内源性组胺在小鼠缺血预处理诱导的脑缺血耐受中的作用[J]. 浙江大学学报（医学版）, 2009, 38(6): 579-583.
[6] 龚子曦;冉珂;常业恬;徐军美. 吗啡后处理对兔心肌缺血再灌注损伤的影响[J]. 浙江大学学报（医学版）, 2009, 38(5): 521-524.
[7] 卢向航，冉珂，徐军美，常业恬. 吗啡预处理对兔心肌缺血再灌注损伤的延迟相保护作用[J]. 浙江大学学报（医学版）, 2009, 38(4): 399-403.
[8] 徐和靖，朱立，汪洋，沈法荣，金红峰，沈岳良，陈莹莹. 钾通道参与高铁血红素诱导的心肌保护作用[J]. 浙江大学学报（医学版）, 2007, 36(1): 7-12.
[9] 夏强，高琴. 缺血预处理、远距预处理和缺血后处理与心肌保护[J]. 浙江大学学报（医学版）, 2007, 36(1): 1-6.
[10] 王珏，高琴，沈佳，叶挺梅，夏强. κ-阿片受体介导缺血后处理的心肌保护作用及其受体后机制[J]. 浙江大学学报（医学版）, 2007, 36(1): 41-47.
[11] 叶挺梅，高琴，李艳芳，王珏，夏强. 缺血后处理与缺血预处理联合应用对长时程心肌缺血/复灌损伤的保护作用[J]. 浙江大学学报（医学版）, 2007, 36(1): 35-40.
[12] 董海正，陈莹莹，朱立，徐和靖，汪洋，沈法荣，蔡朱男，沈岳良. COX-2和HO-1参与缓激肽诱发的晚期心肌保护作用[J]. 浙江大学学报（医学版）, 2007, 36(1): 13-20.
[13] 汤碧娥，陈莹莹，郭炜，梅迪森，徐庆，胡野，沈岳良，夏强. COX-2参与U50488H诱导的延迟性心肌保护作用[J]. 浙江大学学报（医学版）, 2006, 35(2): 165-171.
[14] 周华，苏海，单江. 茶色素预处理对家兔实验性心肌梗塞范围及心肌细胞损伤的影响[J]. 浙江大学学报（医学版）, 2001, 30(5): 215-218.
[15] 蒋华, 虞燕琴, 蒋峻, 张蓓, 沈岳良, 夏强. ATP敏感性钾通道在大鼠心肌缺血预处理中的作用[J]. 浙江大学学报（医学版）, 1999, 28(6): 241-244.